Common Contracts
5 similar Executive Employment Agreement contracts by D8 Holdings Corp., X4 Pharmaceuticals, Inc
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 15th, 2021 • D8 Holdings Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Massachusetts
This Executive Employment Agreement (the “Agreement”), is made and entered into this 13th day of July, 2021 (the “Execution Date”), and is by and between Vicarious Surgical Inc. (“Company”), and Adam Sachs (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 15th, 2021 • D8 Holdings Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Massachusetts
This Executive Employment Agreement (the “Agreement”), is made and entered into this 13th day of July, 2021 (the “Execution Date”), and is by and between Vicarious Surgical Inc. (“Company”), and June Morris (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 15th, 2021 • D8 Holdings Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Massachusetts
This Executive Employment Agreement (the “Agreement”), is made and entered into this 13th day of July, 2021 (the “Execution Date”), and is by and between Vicarious Surgical Inc. (“Company”), and William Kelly (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 15th, 2021 • D8 Holdings Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Massachusetts
This Executive Employment Agreement (the “Agreement”), is made and entered into this 13th day of July, 2021 (the “Execution Date”), and is by and between Vicarious Surgical Inc. (“Company”), and Sammy Khalifa (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 12th, 2020 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Massachusetts
This Executive Employment Agreement (the “Agreement”), is made and entered into this 22nd day of April, 2019 (the “Effective Date”), and is by and between X4 Pharmaceuticals, Inc. (“Company”), and E. Lynne Kelley, M.D. (“Executive”).
